AleAnna, Inc. (ANNA)
| Market Cap | 600.32M |
| Revenue (ttm) | 648,328 |
| Net Income (ttm) | -162.45M |
| Shares Out | 66.55M |
| EPS (ttm) | -609.57 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,649 |
| Open | 9.85 |
| Previous Close | 8.95 |
| Day's Range | 8.88 - 9.99 |
| 52-Week Range | 5.82 - 18.70 |
| Beta | 0.34 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ANNA
AleAnna, Inc., a natural gas resource company, focuses on delivering critical natural gas supplies in Italy. It operates through onshore conventional natural gas exploration and renewable natural gas development. The company was founded in 2007 and is headquartered in Dallas, Texas. [Read more]
Financial Performance
Financial StatementsNews
AleAnna, Inc. To Celebrates Public Listing With NASDAQ Bell-Ringing Ceremony
AleAnna Celebrates Milestone As It Contributes To Europe's Access To Secure And Sustainable Energy And Leads In The Transition To Low Carbon Energy Solutions AleAnna Celebrates Milestone As It Contrib...
AleAnna Announces Signing of Gas Sale Contract with Shell Energy Europe
AleAnna Secures A Contract To Sell Its Gas To Shell Energy Europe Ltd, A Leading Natural Gas, Power And Environmental Trading Company Across European Markets AleAnna has signed a multi-year gas sales ...
AleAnna, Inc. Announces Completion of Several Major Milestones for its Renewable Natural Gas (RNG) Business
DALLAS and ROME, Dec. 18, 2024 (GLOBE NEWSWIRE) -- AleAnna, Inc., (“AleAnna” or the “Company”) (Nasdaq: ANNA), today announced the completion of a series of initiatives through which the Company has e...
BRS Resources Announces Update on AleAnna Energy, LLC
Vancouver, British Columbia--(Newsfile Corp. - December 16, 2024) - BRS RESOURCES LTD. (CSE: BRS) (the "Company" or "BRS"), a mineral exploration company, is pleased to provide an update on its member...
HDL Therapeutics to Go Public in Merger with Swiftmerge Acquisition Corp.
NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $ipo #Consumer--HDL Therapeutics, Inc. (“HDL Therapeutics”), a privately held commercial stage biotech company with an FDA-approved cardiovascular ther...
HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment
NEW YORK & VERO BEACH, Fla.--(BUSINESS WIRE)---- $health #Consumer--NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special pu...